iShares Genomics Immunology and Healthcare ETF
IDNA
58 hedge funds and large institutions have $48.8M invested in iShares Genomics Immunology and Healthcare ETF in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 7 closing their positions.
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
18% more capital invested
Capital invested by funds: $41.3M → $48.8M (+$7.49M)
9.75% more ownership
Funds ownership: 29.48% → 39.23% (+9.7%)
9% more funds holding
Funds holding: 53 → 58 (+5)
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$6.29M |
| 2 |
FTUS
Flow Traders U.S.
New York
|
+$2.26M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.51M |
| 4 |
Lido Advisors
Los Angeles,
California
|
+$1.2M |
| 5 |
TW
Transform Wealth
Greenwood Village,
Colorado
|
+$765K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$2.82M |
| 2 |
VWA
Visionary Wealth Advisors
O'fallon,
Illinois
|
-$700K |
| 3 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$218K |
| 4 |
FHC
First Heartland Consultants
Lake St. Louis,
Missouri
|
-$211K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$125K |
IDNA Hedge Fund Activity: Q4 2024 in Review
58 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q4 2024, worth a combined $48.8M — up 18% from $41.3M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new IDNA positions and 7 closed out — a net gain of 6 holders — while 15 added to existing stakes and 16 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $6.29M. The largest seller was Bank of America, cutting an estimated $2.82M.
- 58 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q4 2024, up from 53 in Q3 2024.
- Funds reported $48.8M of iShares Genomics Immunology and Healthcare ETF stock for Q4 2024, up 18% quarter-over-quarter.
- 13 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q4 2024 and 7 closed out, a net change of +6 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q4 2024 was Morgan Stanley, an estimated $6.29M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q4 2024 was Bank of America, an estimated $2.82M sold.
Based on aggregated 13F filings for Q4 2024.